3rd Annual Pharmaceutical Portfolio Strategy & Management Conference

In the highly-competitive pharmaceutical marketplace, where the commercial success of the company depends on the strategic allocation of resources among projects in the pipeline, portfolio managers aim to continuously improve processes to ensure optimal decisions are made to efficiently prioritize efforts. Taking into account the uncertainty of the narrowing market, portfolio leaders recognize that effective prioritization must go beyond quantitative factors to also include qualitative elements such as the competitive landscape, timing, and complexity of clinical trials required, as well as considerations regarding the potential for geographic expansion and movement into new therapeutic areas. Taking into account all necessary considerations in the decision-making process remains the critical task of portfolio strategy and management professionals, in particular with respect to emerging technology and early-phase programs.

 

The 3rd edition of the Q1 Productions Pharmaceutical Portfolio Strategy & Management Conference will virtually connect industry leaders to share successful methods for quantifying risk, practically address challenges presented by the narrowing marketplace, and shed light on existing and potential use of machine learning within pipeline decision-making. Content will be delivered in three half-day modules to maximize learning and engagement:

 

Module 1:  Enhancing Project Prioritization & Portfolio Optimization Activities Through Risk Identification & Mitigation Strategies    

Module 2:  Developing Effective Criteria to Track Program Advancement & Quantify Potential Success of Candidates in Pipeline    

Module 3: Applying Machine Learning & Data Analytics to Optimize Project Prioritization Strategies

 

Individual modules are available for $595. The entire course may be accessed for $1,500.